Finance Commission holds meeting with Health Minister and senior officials
Also present at the meeting were representatives of High-Level Group on Health Sector set up by the Commission - Dr. Randeep Guleria, Director, AIIMS; Dr. Devi Shetty, Chairman, Narayana Health City, Bengaluru and Prof. K. Srinath Reddy, President, Public Health Foundation of India.
- Country:
- India
The 15th Finance Commission headed by Chairman, Shri N.K. Singh today held a meeting with the Minister for Health and Family Welfare, Dr. Harsh Vardhan and other senior officials from his Ministry. Also present at the meeting were representatives of High-Level Group on Health Sector set up by the Commission - Dr. Randeep Guleria, Director, AIIMS; Dr. Devi Shetty, Chairman, Narayana Health City, Bengaluru and Prof. K. Srinath Reddy, President, Public Health Foundation of India.
The High-Level Group presented the recommendations of their Report on the Health Sector on the aspects of –
Regulatory Framework of the Health Sector.
Human Resource for Health
Public Health expenditure
Strengthening Public Healthcare Delivery System
AYUSH –Integrative approach
The Secretary, Ministry of Health, Ms. Preeti Sudan also presented to the Commission, the Ministry of Health’s submission to the Finance Commission.
It included the National Health Policy 2017, Targets, Resources required, DOHFW Proposal and Composite Health Index, Proposal for Sector-Specific Grants, Key Programme Requirements, AB-PMJAY Requirements.
Following the discussions on incentives/ grants for the Health Sector based on the Terms of Reference of the Commission, the Commission has assured to make careful consideration of all the recommendations before submitting its report to the Government.
(With Inputs from PIB)
ALSO READ
FDA Steers Through Criticism, Expansions, and Innovation in Health Sector
India's Ayush Visa: Paving the Way for Global Health Tourism
Latest Health Sector Developments: Key Updates on Drugs and Diseases
India to Celebrate 'Ayush Medical Coding and Records Day' Annually
Health Sector Faces Challenges Amid Drug Trials, Legislation, and Climate Concerns